نتایج جستجو برای: idiopathic pulmonary fibrosis

تعداد نتایج: 345058  

Journal: :American journal of physiology. Cell physiology 2014
Cong Wang Huiming Zhu Zhaorui Sun Zou Xiang Yuanyuan Ge Can Ni Zhaowen Luo Weiping Qian Xiaodong Han

Idiopathic pulmonary fibrosis is a progressive lung disorder of unknown etiology. Previous studies have shown that aberrant activation of the Wnt/β-catenin signaling cascade occurs in lungs of patients with idiopathic pulmonary fibrosis. Given the important roles of the Wnt/β-catenin signaling pathway in the development of pulmonary fibrosis, we targeted this pathway for the intervention of pul...

Journal: :Pneumologie 1984
A Prasse

Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia and a disease of the elderly. Cigarette smoking and longterm exposure to substances harming alveolar epithelial cells are risk factors for the development of IPF. There is also evidence for a genetic susceptibility. IPF is defined as the idiopathic variant of Usual Interstitial Pneumonitis (UIP). Diagnosis ...

Journal: :Orphanet Journal of Rare Diseases 2008
Eric B Meltzer Paul W Noble

Idiopathic pulmonary fibrosis (IPF) is a non-neoplastic pulmonary disease that is characterized by the formation of scar tissue within the lungs in the absence of any known provocation. IPF is a rare disease which affects approximately 5 million persons worldwide. The prevalence is estimated to be slightly greater in men (20.2/100,000) than in women (13.2/100,000). The mean age at presentation ...

Journal: :Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2014
Sven Lehmann Madlen Uhlemann Sergey Leontyev Joerg Seeburger Jens Garbade Denis R Merk Hartmuth B Bittner Friedrich W Mohr

OBJECTIVES It is unknown if uni- or bilateral lung transplant is best for treatment of usual idiopathic pulmonary fibrosis. We reviewed our single-center experience comparing both treatments. MATERIALS AND METHODS Between 2002 and 2011, one hundred thirty-eight patients at our institution underwent a lung transplant. Of these, 58 patients presented with idiopathic pulmonary fibrosis (56.9%) a...

Journal: :Respiration; international review of thoracic diseases 2012
Virginie Simon-Blancal Olivia Freynet Hilario Nunes Diane Bouvry Nicolas Naggara Pierre-Yves Brillet Damien Denis Yves Cohen François Vincent Dominique Valeyre Jean-Marc Naccache

BACKGROUND Acute exacerbation is a substantial cause of death in patients with idiopathic pulmonary fibrosis with poorly described prognostic factors. OBJECTIVES To review the features associated with acute exacerbation of idiopathic pulmonary fibrosis and assess its prognostic factors. METHODS Thirty-seven occurrences of acute exacerbation of idiopathic pulmonary fibrosis were retrospectiv...

2015
Amit Kishore Veronika Žižková Lenka Kocourková Martin Petřek

Citation: Kishore A, Žižková V, Kocourková L and Petřek M (2015) A dataset of 26 candidate gene and pro-inflammatory cytokine variants for association studies in idiopathic pulmonary fibrosis: frequency distribution in normal Czech population. Front. Immunol. 6:476. doi: 10.3389/fimmu.2015.00476 a dataset of 26 candidate gene and pro-inflammatory cytokine variants for association studies in idi...

2018
Michela Terlizzi Antonio Molino Chiara Colarusso Chantal Donovan Pasquale Imitazione Pasquale Somma Rita P. Aquino Philip M. Hansbro Aldo Pinto Rosalinda Sorrentino

Citation: Terlizzi M, Molino A, Colarusso C, Donovan C, Imitazione P, Somma P, Aquino RP, Hansbro PM, Pinto A and Sorrentino R (2018) Activation of the Absent in Melanoma 2 Inflammasome in Peripheral Blood Mononuclear Cells From Idiopathic Pulmonary Fibrosis Patients Leads to the Release of Pro-Fibrotic Mediators. Front. Immunol. 9:670. doi: 10.3389/fimmu.2018.00670 activation of the absent in ...

Journal: :Immunology and allergy clinics of North America 2012
Jason S Zolak Joao A de Andrade

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease of unknown cause characterized by progressive scarring of the lung parenchyma and relentless loss of lung function. The diagnosis depends on close collaboration between clinicians, radiologists, and pathologists. No therapies approved by the Food and Drug Administration are available for IPF, and an analysis of completed clinical tri...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید